These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28886341)

  • 1. CDK10 Mutations in Humans and Mice Cause Severe Growth Retardation, Spine Malformations, and Developmental Delays.
    Windpassinger C; Piard J; Bonnard C; Alfadhel M; Lim S; Bisteau X; Blouin S; Ali NB; Ng AYJ; Lu H; Tohari S; Talib SZA; van Hul N; Caldez MJ; Van Maldergem L; Yigit G; Kayserili H; Youssef SA; Coppola V; de Bruin A; Tessarollo L; Choi H; Rupp V; Roetzer K; Roschger P; Klaushofer K; Altmüller J; Roy S; Venkatesh B; Ganger R; Grill F; Ben Chehida F; Wollnik B; Altunoglu U; Al Kaissi A; Reversade B; Kaldis P
    Am J Hum Genet; 2017 Sep; 101(3):391-403. PubMed ID: 28886341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAR syndrome-associated CDK10/Cyclin M regulates actin network architecture and ciliogenesis.
    Guen VJ; Gamble C; Perez DE; Bourassa S; Zappel H; Gärtner J; Lees JA; Colas P
    Cell Cycle; 2016; 15(5):678-88. PubMed ID: 27104747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A homozygous deleterious CDK10 mutation in a patient with agenesis of corpus callosum, retinopathy, and deafness.
    Guen VJ; Edvardson S; Fraenkel ND; Fattal-Valevski A; Jalas C; Anteby I; Shaag A; Dor T; Gillis D; Kerem E; Lees JA; Colas P; Elpeleg O
    Am J Med Genet A; 2018 Jan; 176(1):92-98. PubMed ID: 29130579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The awakening of the CDK10/Cyclin M protein kinase.
    Guen VJ; Gamble C; Lees JA; Colas P
    Oncotarget; 2017 Jul; 8(30):50174-50186. PubMed ID: 28178678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders.
    Robert T; Dock-Bregeon AC; Colas P
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1782. PubMed ID: 34369103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
    Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
    Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome.
    Guen VJ; Gamble C; Flajolet M; Unger S; Thollet A; Ferandin Y; Superti-Furga A; Cohen PA; Meijer L; Colas P
    Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19525-30. PubMed ID: 24218572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of cyclin-dependent kinase 10 (cdk10) gene impairs neural progenitor survival via modulation of raf1a gene expression.
    Yeh CW; Kao SH; Cheng YC; Hsu LS
    J Biol Chem; 2013 Sep; 288(39):27927-39. PubMed ID: 23902762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle.
    Bagella L; Giacinti C; Simone C; Giordano A
    J Cell Biochem; 2006 Oct; 99(3):978-85. PubMed ID: 16741970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bi-allelic TMEM94 Truncating Variants Are Associated with Neurodevelopmental Delay, Congenital Heart Defects, and Distinct Facial Dysmorphism.
    Stephen J; Maddirevula S; Nampoothiri S; Burke JD; Herzog M; Shukla A; Steindl K; Eskin A; Patil SJ; Joset P; Lee H; Garrett LJ; Yokoyama T; Balanda N; Bodine SP; Tolman NJ; Zerfas PM; Zheng A; Ramantani G; Girisha KM; Rivas C; Suresh PV; Elkahloun A; Alsaif HS; Wakil SM; Mahmoud L; Ali R; Prochazkova M; ; Kulkarni AB; Ben-Omran T; Colak D; Morris HD; Rauch A; Martinez-Agosto JA; Nelson SF; Alkuraya FS; Gahl WA; Malicdan MCV
    Am J Hum Genet; 2018 Dec; 103(6):948-967. PubMed ID: 30526868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity.
    Kasten M; Giordano A
    Oncogene; 2001 Apr; 20(15):1832-8. PubMed ID: 11313931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-I receptor mutations and intrauterine and postnatal growth retardation.
    Unger S
    N Engl J Med; 2004 Mar; 350(13):1362-3; author reply 1362-3. PubMed ID: 15044651
    [No Abstract]   [Full Text] [Related]  

  • 13. Recessive NEK9 mutation causes a lethal skeletal dysplasia with evidence of cell cycle and ciliary defects.
    Casey JP; Brennan K; Scheidel N; McGettigan P; Lavin PT; Carter S; Ennis S; Dorkins H; Ghali N; Blacque OE; Mc Gee MM; Murphy H; Lynch SA
    Hum Mol Genet; 2016 May; 25(9):1824-35. PubMed ID: 26908619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKN2 is essential for mouse embryonic development and proliferation of mouse fibroblasts.
    Danno S; Kubouchi K; Mehruba M; Abe M; Natsume R; Sakimura K; Eguchi S; Oka M; Hirashima M; Yasuda H; Mukai H
    Genes Cells; 2017 Feb; 22(2):220-236. PubMed ID: 28102564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation.
    Takahashi K; Nakayama K; Nakayama K
    J Biochem; 2000 Jan; 127(1):73-83. PubMed ID: 10731669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes.
    Türkmen S; Gillessen-Kaesbach G; Meinecke P; Albrecht B; Neumann LM; Hesse V; Palanduz S; Balg S; Majewski F; Fuchs S; Zschieschang P; Greiwe M; Mennicke K; Kreuz FR; Dehmel HJ; Rodeck B; Kunze J; Tinschert S; Mundlos S; Horn D
    Eur J Hum Genet; 2003 Nov; 11(11):858-65. PubMed ID: 14571271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joubert Syndrome in French Canadians and Identification of Mutations in CEP104.
    Srour M; Hamdan FF; McKnight D; Davis E; Mandel H; Schwartzentruber J; Martin B; Patry L; Nassif C; Dionne-Laporte A; Ospina LH; Lemyre E; Massicotte C; Laframboise R; Maranda B; Labuda D; Décarie JC; Rypens F; Goldsher D; Fallet-Bianco C; Soucy JF; Laberge AM; Maftei C; ; Boycott K; Brais B; Boucher RM; Rouleau GA; Katsanis N; Majewski J; Elpeleg O; Kukolich MK; Shalev S; Michaud JL
    Am J Hum Genet; 2015 Nov; 97(5):744-53. PubMed ID: 26477546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biological significance of Cdk10 in hepatocellular carcinoma.
    Zhong XY; Xu XX; Yu JH; Jiang GX; Yu Y; Tai S; Wang ZD; Cui YF
    Gene; 2012 Apr; 498(1):68-74. PubMed ID: 22326270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation.
    Abuzzahab MJ; Schneider A; Goddard A; Grigorescu F; Lautier C; Keller E; Kiess W; Klammt J; Kratzsch J; Osgood D; Pfäffle R; Raile K; Seidel B; Smith RJ; Chernausek SD;
    N Engl J Med; 2003 Dec; 349(23):2211-22. PubMed ID: 14657428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the cyclin-dependent kinase 10 (CDK10) on the tamoxifen sensitivity of keloid samples.
    Liu Y; Xiao Z; Yang D; Ren L; Liu G; Yang L
    Molecules; 2012 Feb; 17(2):1307-18. PubMed ID: 22298115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.